1. Home
  2. GSAT vs PTCT Comparison

GSAT vs PTCT Comparison

Compare GSAT & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globalstar Inc.

GSAT

Globalstar Inc.

HOLD

Current Price

$68.44

Market Cap

7.5B

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$77.28

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSAT
PTCT
Founded
2003
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
5.3B
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
GSAT
PTCT
Price
$68.44
$77.28
Analyst Decision
Strong Buy
Buy
Analyst Count
4
17
Target Price
$52.75
$73.76
AVG Volume (30 Days)
1.0M
2.3M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
8.94
Revenue
$262,202,000.00
$1,779,150,000.00
Revenue This Year
$10.89
$128.32
Revenue Next Year
$10.07
N/A
P/E Ratio
N/A
$8.64
Revenue Growth
8.54
97.54
52 Week Low
$17.24
$35.95
52 Week High
$70.83
$87.50

Technical Indicators

Market Signals
Indicator
GSAT
PTCT
Relative Strength Index (RSI) 71.09 54.29
Support Level $58.02 $73.03
Resistance Level $62.68 $79.03
Average True Range (ATR) 3.73 3.38
MACD 0.30 -0.70
Stochastic Oscillator 85.91 29.37

Price Performance

Historical Comparison
GSAT
PTCT

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: